These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 1977666

  • 1. Clinical usefulness of serum sialyl SSEA-1 antigen levels in patients with epithelial ovarian cancer. Comparative effectiveness of sialyl SSEA-1 and CA 125.
    Kobayashi H, Kawashima Y.
    Gynecol Obstet Invest; 1990; 30(1):52-8. PubMed ID: 1977666
    [Abstract] [Full Text] [Related]

  • 2. [Basic and clinical evaluation of an immunoradiometric competitive inhibition assay for sialyl TN antigen: (2). Evaluation of clinical significance. STN Study Group].
    Imura H, Mori T, Ohkura H, Ishii M, Ariyoshi H, Endo J, Kitao M, Takeda I, Kobayashi H, Inoue M.
    Gan To Kagaku Ryoho; 1989 Sep; 16(9):3221-30. PubMed ID: 2571323
    [Abstract] [Full Text] [Related]

  • 3. [The clinical usefulness of the measurement of serum sialyl SSEA-1 antigen levels in patients with gynecologic diseases: as respects the comparative effectiveness of sialyl SSEA-1 and CA125].
    Kobayashi H.
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 Jul; 40(7):828-34. PubMed ID: 3166483
    [Abstract] [Full Text] [Related]

  • 4. Clinical usefulness of sialyl SSEA-1 antigen as tumor marker for ovarian cancer as compared with CA125, CA19-9, TPA, IAP, CEA and ferritin.
    Yabushita H, Sawaguchi K, Hieda S, Ogawa A, Tomatsu A, Noguchi M, Ishihara M.
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Feb; 41(2):217-24. PubMed ID: 2566639
    [Abstract] [Full Text] [Related]

  • 5. [The clinical significance of serum sialyl SSEA-1 antigen in obstetrical and gynecological patients].
    Tanaka T, Iwasaka T, Hayashi Y, Hachisuga T, Yokoyama M, Ohkuma Y, Matsuo N, Fukuda K, Sugimori H.
    Nihon Gan Chiryo Gakkai Shi; 1990 Jun 20; 25(6):1157-61. PubMed ID: 1975831
    [Abstract] [Full Text] [Related]

  • 6. Clinical evaluation of circulating serum sialyl Tn antigen levels in patients with epithelial ovarian cancer.
    Kobayashi H, Terao T, Kawashima Y.
    J Clin Oncol; 1991 Jun 20; 9(6):983-7. PubMed ID: 1851822
    [Abstract] [Full Text] [Related]

  • 7. Preoperative determination of several serum tumor markers in patients with primary epithelial ovarian carcinoma.
    Kudoh K, Kikuchi Y, Kita T, Tode T, Takano M, Hirata J, Mano Y, Yamamoto K, Nagata I.
    Gynecol Obstet Invest; 1999 Jun 20; 47(1):52-7. PubMed ID: 9852392
    [Abstract] [Full Text] [Related]

  • 8. Clinical value of sialyl SSEA-1 antigen in patients with ovarian cancer.
    Suzuki M, Ohwada M, Tamada T.
    Gynecol Oncol; 1990 Mar 20; 36(3):371-5. PubMed ID: 1969379
    [Abstract] [Full Text] [Related]

  • 9. [The clinical value of sialyl SSEA-1 antigen in patients with gynecologic tumors].
    Inoue M, Shimizu C, Sasagawa T, Shimizu H, Saitoh J, Ueda G, Tanizawa O, Kimura T, Kawata M, Taniguchi T.
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Dec 20; 39(12):2120-4. PubMed ID: 2892886
    [Abstract] [Full Text] [Related]

  • 10. Clinical evaluations of the tumor marker sialyl SSEA-1 antigen for clinical gynecological disease.
    Iwanari O, Miyako J, Date Y, Nakayama S, Kijima S, Moriyama M, Karino K, Endoh J, Kitao M.
    Gynecol Obstet Invest; 1990 Dec 20; 29(3):214-8. PubMed ID: 1972688
    [Abstract] [Full Text] [Related]

  • 11. Sialyl-Tn, sialyl-Lewis Xi, CA 19-9, CA 125, carcinoembryonic antigen, and tissue polypeptide antigen in differentiating ovarian cancer from benign tumors.
    Inoue M, Fujita M, Nakazawa A, Ogawa H, Tanizawa O.
    Obstet Gynecol; 1992 Mar 20; 79(3):434-40. PubMed ID: 1346716
    [Abstract] [Full Text] [Related]

  • 12. Sialyl stage-specific embryonic antigen-1: a useful marker for differentiating the etiology of pleural effusion.
    Lee YC, Chern JH, Lai SL, Perng RP.
    Chest; 1998 Dec 20; 114(6):1542-5. PubMed ID: 9872185
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Characterisation and clinical usefulness of CA130 antigen recognised by monoclonal antibodies, 130-22 and 145-9, in ovarian cancers.
    Kobayashi H, Ohi H, Fujii T, Terao T.
    Br J Cancer; 1993 Feb 20; 67(2):237-43. PubMed ID: 7679280
    [Abstract] [Full Text] [Related]

  • 18. Cancer-associated antigen CA 195 in patients with mucinous ovarian tumours: a comparative analysis with CEA, TATI and CA 125 in serum specimens and cyst fluids.
    de Bruijn HW, ten Hoor KA, Boonstra H, Marrink J, Krans M, Aalders JG.
    Tumour Biol; 1993 Feb 20; 14(2):105-15. PubMed ID: 8392219
    [Abstract] [Full Text] [Related]

  • 19. [Cancer-associated carbohydrate antigens available for serum diagnosis].
    Sawabu N, Takemori Y, Satomura Y, Watanabe H, Kawakami H, Hattori N.
    Gan To Kagaku Ryoho; 1988 Apr 20; 15(4 Pt 2-1):1091-101. PubMed ID: 2898921
    [Abstract] [Full Text] [Related]

  • 20. Differentiation-dependent expression of sialyl stage-specific embryonic antigen-1 and I-antigens on human lymphoid cells and its implications for carbohydrate-mediated adhesion to vascular endothelium.
    Ohmori K, Takada A, Yoneda T, Buma Y, Hirashima K, Tsuyuoka K, Hasegawa A, Kannagi R.
    Blood; 1993 Jan 01; 81(1):101-11. PubMed ID: 8093344
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.